Advertisement

The epidemiology of Chlamydia pneumoniae versus the epidemiology of potential Chlamydial diseases (Atherosclerosis, Multiple Sclerosis, M. Alzheimer)

  • W. Stille
  • C. Stephan
  • M. Madeo
  • E. Bauer-Krylov
Conference paper

Keywords

Multiple Sclerosis Chlamydial Infection Antibiotic Policy Vascular Infection Coronary Infarction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP, Herderick EE, Cornhill JF. (1999) Prevalence and Extent of Atherosclerosis in Adolescents and Young Adults. JAMA 281(8): 727–735PubMedCrossRefGoogle Scholar
  2. 2.
    Enos WF, Holmes RH, Beyer J. (1953) Coronary disease among United States soldiers killed in action in Korea. JAMA 152: 1090–1093CrossRefGoogle Scholar
  3. 3.
    Ross R, Glomset JA. (1976) The pathogenesis of atherosclerosis. N Engl J Med 295(7): 369–377CrossRefGoogle Scholar
  4. 4.
    Ross R. (1999) Atherosclerosis-An inflammatory disease. N Engl J Med 340(2): 115–126PubMedCrossRefGoogle Scholar
  5. 5.
    Kurtzke JF, Hyllested K, Heltberg A. (1993) Multiple Sclerosis in the Faroes. In: Firnhaber W, Lauer K (eds) Multiple Sclerosis in Europe. Leuchtturm-Verlag/LTV Press, Alsbach/BergstraβeGoogle Scholar
  6. 6.
    Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP. (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol 187(1): 23–42PubMedCrossRefGoogle Scholar
  7. 7.
    Jorm AF. (1990) The epidemiology of Alzheimer’s disease and related disorders. Chapman and Hall, LondonGoogle Scholar
  8. 8.
    Blasi F, Cosentini R, Schoeller MC, Lupo A, Allegra L. (1993) Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. Thorax 48: 1261–1263PubMedCrossRefGoogle Scholar
  9. 9.
    Normann E, Gnarpe J, Gnarpe H, Wettergren B. (1998) Chlamydia pneumoniae in children attending day-care centers in Gavle, Sweden. Pediatr Infect Dis J 17(6): 474–478PubMedCrossRefGoogle Scholar
  10. 10.
    Maass M, Bartels C, Kruger S, Krause E, Engel PM, Dalhoff K. (1998) Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 140 Suppl 1: S25-S30Google Scholar
  11. 11.
    Taylor-Robinson D, Ong G, Thomas BJ, Rose ML, Yacoub MH. (1998) Chlamydia pneumoniae in vascular tissues from heart-transplant donors. Lancet 351(9111): 1255PubMedCrossRefGoogle Scholar
  12. 12.
    Willich S, Lowel H, Mey W, Trautner C. (1999) Regionale Unterschiede der Herz-Kreislauf-Mortalität in Deutschland. Dt Ärztebl 96: A–483–488Google Scholar
  13. 13.
    Änestad G, Scheel O, Hungnes O. (1997) Chronic infections and coronary heart disease. Lancet 350: 1028PubMedCrossRefGoogle Scholar
  14. 14.
    Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. (1999) Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 281(5): 427–431PubMedCrossRefGoogle Scholar
  15. 15.
    Hall K, Gureje O, Gao S, Ogunniyi A, Hui SL, Baiyewu O, Unverzagt FW, Oluwole S, Hendrie HC. (1998) Risk factors and Alzheimer’s disease: a comparative study of two communities. Aust N Z J Psychiatry 32(5): 698–706PubMedCrossRefGoogle Scholar
  16. 16.
    United Nations. (1996) Demographic Yearbook 1994, New YorkGoogle Scholar
  17. 17.
    Lauer K. (1993) Epidemiologie der multiplen Sklerose. In: Henkes H, Kolmel HW (eds) Die entztindlichen Erkrankungen des Zentralnervensystems: Handbuch und Atlas. (3. Ergänzungslieferung 2/1997). Ecomed, Landsberg/LechGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • W. Stille
  • C. Stephan
  • M. Madeo
  • E. Bauer-Krylov

There are no affiliations available

Personalised recommendations